Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study

CONCLUSION: Patients who initiated galcanezumab for migraine prevention had higher treatment adherence and persistence compared with those who initiated SOC medications after 24-month follow-up.PMID:38334320 | DOI:10.1080/03007995.2024.2316864

Source: Current Medical Research and Opinion - February 9, 2024 Category: Research Authors: Oralee J Varnado Michelle Vu Erin Buysman Gilwan Kim Gayle Allenback Margaret Hoyt Helen Trenz Feng Cao Lars Viktrup Source Type: research